HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q2 2023 vs. Q1 2023
How the institutions holding HUTCHMED (China) Ltd changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 71 | 70 | −1 |
| Shares | 24.6M | 24.1M | −577.2K (−2.3%) |
| Value | $320.6M | $266.1M | −$54.5M (−17.0%) |
New holders (8)
Institutions that held HUTCHMED (China) Ltd at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hennion & Walsh Asset Management, Inc. | 27,298 | $328.0K | 0.02% |
| Exchange Traded Concepts, LLC | 16,671 | $200.1K | 0.00% |
| Envestnet Asset Management Inc | 15,401 | $184.8K | 0.00% |
| Squarepoint Ops LLC | 14,236 | $170.8K | 0.00% |
| Rathbone Brothers plc | 10,450 | $125.4K | 0.00% |
| Deutsche Bank AG | 8,822 | $105.9K | 0.00% |
| Rhumbline Advisers | 8,104 | $97.2K | 0.00% |
| Simplex Trading, LLC | 20 | $0 | 0.00% |
Sold out (9)
Institutions that held HUTCHMED (China) Ltd at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Ergoteles LLC | 110,480 | $1.44M |
| HRT Financial LP | 68,860 | $896.0K |
| Y-Intercept (Hong Kong) Ltd | 17,461 | $227.3K |
| Credit Suisse AG | 13,548 | $176.4K |
| Mariner, LLC | 11,325 | $148.0K |
| JustInvest LLC | 10,075 | $131.2K |
| Quantbot Technologies LP | 3,824 | $49.8K |
| Robeco Institutional Asset Management B.V. | 884 | $11.5K |
| Ronald Blue Trust, Inc. | 271 | $4.00K |